Resveratrol Derivatives Inhibit Transthyretin Fibrillization: Structural Insights into the Interactions between Resveratrol Derivatives and Transthyretin
Journal of Medicinal Chemistry · 23.11.2023 · 66 (22) · 15511-15523
DOI: 10.1021/acs.jmedchem.3c01698 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 01.11.2023. Verfasst von Takeshi Yokoyama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0914, Japan. Hauptthemen laut MEDLINE: Amyloidosis, Amyloid Neuropathies, Familial. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Takeda Science Foundation, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Hereditary ATTR amyloidosis is a disease caused by the deposition of amyloid fibrils formed by mutated transthyretin (TTR), a protein that binds to thyroid hormone in the serum, in the organs. The development of a small molecule that binds to and stabilizes TTR is a promising strategy for the treatment of ATTR amyloidosis. In the present study, we demonstrated that the resveratrol derivatives including pterostilbene available as a dietary supplement inhibit the fibrillization of V30M-TTR to the same extent as the approved drug tafamidis. Furthermore, based on a thermodynamic and X-ray crystallographic analysis, the binding of the resveratrol derivative to TTR was shown to be enthalpy-driven, with the binding enthalpy being acquired by hydrogen bonding to S117. Moreover, direct observation of hydrogen atoms by neutron crystallography provided details of the hydrogen bond network by S117 and emphasized the importance of the CH···π interaction by L110 in the ligand binding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0914, Japan.
- Neutron Industrial Application Promotion Center, Comprehensive Research Organization for Science and Society (CROSS), 162-1 Shirakata, Tokai 319-1106, Ibaraki, Japan.
- Institute for Quantum Biology, National Institutes for Quantum Science and Technology, 2-4 Shirakata, Tokai 319-1106, Ibaraki, Japan.
ORCID-Profile: Takeshi Yokoyama, Satoru Fujiwara
Förderung
- Takeda Science Foundation
- Japan Society for the Promotion of Science
Zitieren
APA
Yokoyama, T., Kusaka, K., Mizuguchi, M., Nabeshima, Y., & Fujiwara, S. (2023). Resveratrol Derivatives Inhibit Transthyretin Fibrillization: Structural Insights into the Interactions between Resveratrol Derivatives and Transthyretin. Journal of Medicinal Chemistry, 66(22), 15511-15523. https://doi.org/10.1021/acs.jmedchem.3c01698
Vancouver
Yokoyama T, Kusaka K, Mizuguchi M, Nabeshima Y, Fujiwara S. Resveratrol Derivatives Inhibit Transthyretin Fibrillization: Structural Insights into the Interactions between Resveratrol Derivatives and Transthyretin. Journal of Medicinal Chemistry. 2023;66(22):15511-15523. doi:10.1021/acs.jmedchem.3c01698
BibTeX
@article{Yokoyama2023,
author = {Yokoyama, Takeshi and Kusaka, Katsuhiro and Mizuguchi, Mineyuki and Nabeshima, Yuko and Fujiwara, Satoru},
title = {Resveratrol Derivatives Inhibit Transthyretin Fibrillization: Structural Insights into the Interactions between Resveratrol Derivatives and Transthyretin},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {22},
pages = {15511--15523},
doi = {10.1021/acs.jmedchem.3c01698}
}
EUVIMED